Euractiv.com

In today's edition: Bioenergy, CAP, food stockpiling

In today's edition: Data omnibus, industrial AI rules cut, digital & space ECF budgets

In today's edition: Tobacco 'endgame', SPC, Biotech

In today's edition: Ukraine, NATO, Germany, UK

MEP will face intense pressure to push the startup reform project through by the end of the year

"Reopening the Strait of Hormuz is not possible amid a blatant violation of the ceasefire"

Also, in Thursday’s edition: ‘soft faces,’ Weber’s secret, Orbán’s farewell

Europe has the resources to scale biomethane and reduce energy dependence, but policy gaps are slowing progress. Without stronger regulatory support and investment certainty, the EU risks missing a strategic opportunity to strengthen energy security and accelerate decarbonisation.

The office of France's ecology minister said the two-day meeting would focus on "less contentious issues" in an effort to appease the most powerful G7 member

Under the deal, France pledged to increase law enforcement on the coast by more than half to fight irregular migration to Britain – reaching 1,400 officers by 2029

Chinese AI firms expand globally despite strict rules at home

Major markets like Germany, France, and Italy saw strong growth

'If this were happening in Mr Orbán’s Hungary, it would have made every democrat’s hair stand on end'

As EU leaders gather in Cyprus to discuss the Gulf crisis, the Iranian opposition figure speaks to Euractiv ahead of meetings in Berlin’s Bundestag

With Russia bogged down in Ukraine, Beijing has overtaken Moscow as the EU's main rival in Serbia

Europe will need more expensive LNG from spot markets as gas stocks hit nine-year low, the regulatory agency says

The EPP alliance that dares not speak its name

Anthropic's new AI can break almost any software system in existence. Europe's access rests on American discretion; only real, hard European leverage can change that

Capitals push back on efforts to fast-track Kyiv’s accession

Reimbursement systems in Belgium and Europe are not prepared for cell and gene therapies